Skip to main content
. 2018 Aug 24;8:12776. doi: 10.1038/s41598-018-30692-3

Figure 4.

Figure 4

The anticancer activity of nuclosamide is mediated by the dysregulation of the Wnt/β-Catenin signaling pathway. TCF/LEF plasmid reporter activity was evaluated in (A) SCC4 and (B) SCC25 cells treated with different concentrations of niclosamide, using the TOPflash assay. Representative western blot data showing the inhibitory effect of niclosamide on the expression levels of β-catenin, DVL2, p-GSK3β, and Cyclin D1 proteins in (C) SCC4 and (D) SCC25 OSCC cells. β-actin was used as loading control. Data represents experiments performed in triplicates and expressed as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001.